{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:45:22Z","timestamp":1789429522884,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jocn.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T18:00:16Z","timestamp":1386525616000},"page":"195-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Statins can induce myasthenia gravis"],"prefix":"10.1016","volume":"21","author":[{"given":"Jesse","family":"Gale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.11.009_b0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.11.009_b0010","doi-asserted-by":"crossref","first-page":"e6562","DOI":"10.1136\/bmj.e6562","article-title":"Rhabdomyolysis after co-prescription of statin and fusidic acid","volume":"345","author":"Kearney","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2013.11.009_b0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-008-0011-4","article-title":"Statin myopathy","volume":"8","author":"Radcliffe","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jocn.2013.11.009_b0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(02)07795-4","article-title":"Statins and myopathy","volume":"359","author":"Hargreaves","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.11.009_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00002018-200225090-00004","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?","volume":"25","author":"Evans","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jocn.2013.11.009_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jocn.2013.11.009_b0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/mus.21074","article-title":"Statins may aggravate myasthenia gravis","volume":"38","author":"Oh","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2013.11.009_b0040","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1212\/01.WNL.0000145708.03876.C3","article-title":"Statin-associated exacerbation of myasthenia gravis","volume":"63","author":"Cartwright","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.11.009_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.md.0000209337.59874.aa","article-title":"Statin-associated myasthenia gravis: report of 4 cases and review of the literature","volume":"85","author":"Purvin","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jocn.2013.11.009_b0050","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1111\/j.1468-1331.2008.02234.x","article-title":"Ptosis, diplopia and statins: an association?","volume":"15","author":"Elsais","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2013.11.009_b0055","first-page":"427","article-title":"Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia","volume":"118","author":"Negvesky","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jocn.2013.11.009_b0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(02)09846-X","article-title":"Statins, fibrates, and ocular myasthenia","volume":"360","author":"Parmar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.11.009_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1752-1947-4-61","article-title":"Statin-associated weakness in myasthenia gravis: a case report","volume":"4","author":"Keogh","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jocn.2013.11.009_b0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(03)12152-6","article-title":"Reversible ocular myasthenia gravis or mitochondrial myopathy from statins?","volume":"361","author":"Engel","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.11.009_b0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1997.00440250045006","article-title":"Drugs and myasthenia gravis. An update","volume":"157","author":"Wittbrodt","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocn.2013.11.009_b0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00005792-199811000-00002","article-title":"Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature","volume":"77","author":"Rudski","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jocn.2013.11.009_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jocn.2013.11.009_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2011.11.005","article-title":"Statins as a possible cause of inflammatory and necrotizing myopathies","volume":"222","author":"Padala","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jocn.2013.11.009_b0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2013.11.009_b0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins","volume":"15","author":"Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jocn.2013.11.009_b0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jocn.2013.11.009_b0110","first-page":"CD008386","article-title":"Statins for multiple sclerosis","author":"Wang","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocn.2013.11.009_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10067-007-0806-8","article-title":"Statintreatment forrheumatoidarthritis: a promising novel indication","volume":"27","author":"Paraskevas","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jocn.2013.11.009_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2013.11.009_b0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaut.2005.06.005","article-title":"Effects of atorvastatin on the Th1\/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats","volume":"25","author":"Liu","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2013.11.009_b0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","article-title":"Isoprenoids determine Th1\/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin","volume":"203","author":"Dunn","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2013.11.009_b0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ncpneuro0988","article-title":"Is it safe to use statins in patients with myasthenia gravis?","volume":"5","author":"Gilhus","year":"2009","journal-title":"Nat Clin Pract Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813006437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813006437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T18:59:53Z","timestamp":1597172393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586813006437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0967586813006437"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.11.009","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins can induce myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}